Tuesday, Jan 9, 2001
South San Francisco, Calif. -- January 9, 2001 --Genentech, Inc. (NYSE: DNA) will announce its 2000 4th quarter/year-end earnings on Thursday, January 18, 2001, after the markets close. The announcement will be followed by a live webcast at 2:30 PM (PST) of a discussion by Genentech management of the earnings and other business results. The webcast can be accessed by going to Genentech's web site at http://www.gene.com and will be archived and available for replay until January 25, 2001.
Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Fourteen of the currently approved biotechnology products stem from Genentech science. Genentech markets nine biotechnology products directly in the United States. The company has headquarters in South San Francisco, California and is traded on the New York Stock Exchange under the symbol DNA.
# # #